ADAP logo

Adaptimmune Therapeutics (ADAP) Enterprise Value

Enterprise Value

$111.28 M
+$3.07 M+2.84%

Wed, 26 Feb 2025 22:20:58 GMT


Summary


Performance

ADAP Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherADAPvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

ADAP Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+2.8%+2.0%+2.0%
1 m1 month+2.4%+1.7%+1.7%
3 m3 months-18.3%-13.9%-13.9%
6 m6 months-33.8%-53.8%-53.9%
ytdytd+15.3%+10.6%+10.6%
1 y1 year-56.5%-59.0%-63.6%
5 y5 years-74.2%-66.4%-82.9%

ADAP Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-3.0%$97 M+14.4%
3 m3-month$147 M-24.4%$97 M+15.3%
6 m6-month$168 M-33.8%$74 M+50.5%
1 y1-year$335 M-66.8%$74 M+50.5%
3 y3-year$369 M-69.9%$31 M+259.5%
5 y5-year$1.69 B-93.4%$31 M+259.5%
alltimeall time$1.69 B-93.4%$31 M+259.5%

Adaptimmune Therapeutics Enterprise Value History

DateValue
2025
$111.28 M(+15.3%)
2024
$96.52 M(+59.0%)
2023
$60.71 M(-60.0%)
2022
$151.70 M(-67.1%)
2021
$461.49 M(-42.4%)
DateValue
2020
$801.16 M(+691.3%)
2019
$101.25 M(-81.0%)
2018
$532.93 M(-1.6%)
2017
$541.78 M(+323.5%)
2016
$127.94 M(-79.9%)
2015
$636.60 M

FAQ

  • What is Adaptimmune Therapeutics enterprise value?
  • What is the all time high enterprise value for Adaptimmune Therapeutics?
  • What is ADAP enterprise value year-to-date change?
  • What is Adaptimmune Therapeutics enterprise value year-on-year change?

What is Adaptimmune Therapeutics enterprise value?

The current enterprise value of ADAP is $111.28 M

What is the all time high enterprise value for Adaptimmune Therapeutics?

Adaptimmune Therapeutics all-time high enterprise value is $1.69 B

What is ADAP enterprise value year-to-date change?

Adaptimmune Therapeutics enterprise value has changed by +$14.76 M (+15.30%) since the beginning of the year

What is Adaptimmune Therapeutics enterprise value year-on-year change?

Over the past year, ADAP enterprise value has changed by -$144.79 M (-56.54%)